MARKET

VXRT

VXRT

VAXART
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4940
-0.0360
-6.79%
After Hours: 0.5000 +0.006 +1.21% 16:11 01/24 EST
OPEN
0.5200
PREV CLOSE
0.5300
HIGH
0.5201
LOW
0.4488
VOLUME
2.40M
TURNOVER
--
52 WEEK HIGH
5.00
52 WEEK LOW
0.2543
MARKET CAP
22.83M
P/E (TTM)
-0.3129
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VXRT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VXRT News

  • Results from Influenza Challenge Study Published in Lancet Infectious Diseases
  • GlobeNewswire.2d ago
  • Hedge Funds Have Never Been This Bullish On Vaxart, Inc. (VXRT)
  • Insider Monkey.12/22/2019 21:44
  • Vaxart EPS beats by $0.03, beats on revenue
  • seekingalpha.11/13/2019 02:49
  • Vaxart Q3 EPS $(0.32) Up From $(0.92) YoY, Sales $454K Up From $281K YoY
  • Benzinga.11/12/2019 21:54

More

Industry

Biotechnology & Medical Research
-2.27%
Pharmaceuticals & Medical Research
-1.88%

Hot Stocks

Name
Price
%Change

About VXRT

Vaxart, Inc., formerly Aviragen Therapeutics, Inc., is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics in Phase IIb SPIRITUS trial; BTA585, an oral fusion (F) protein inhibitor in Phase II development for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in Phase II development for condyloma caused by human papillomavirus Types 6 and 11. It has preclinical RSV non-fusion inhibitor program. It has focused its research and drug development capabilities on discovering and developing small molecule compounds that can prevent or treat infectious diseases.
More

Webull offers Vaxart Inc (VXRT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.